Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1242/JCS.080762 | ||||
| Año | 2011 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Increasing evidence indicates that endoplasmic reticulum (ER) stress activates the adaptive unfolded protein response (UPR), but that beyond a certain degree of ER damage, this response triggers apoptotic pathways. The general mechanisms of the UPR and its apoptotic pathways are well characterized. However, the metabolic events that occur during the adaptive phase of ER stress, before the cell death response, remain unknown. Here, we show that, during the onset of ER stress, the reticular and mitochondrial networks are redistributed towards the perinuclear area and their points of connection are increased in a microtubule-dependent fashion. A localized increase in mitochondrial transmembrane potential is observed only in redistributed mitochondria, whereas mitochondria that remain in other subcellular zones display no significant changes. Spatial re-organization of these organelles correlates with an increase in ATP levels, oxygen consumption, reductive power and increased mitochondrial Ca2+ uptake. Accordingly, uncoupling of the organelles or blocking Ca2+ transfer impaired the metabolic response, rendering cells more vulnerable to ER stress. Overall, these data indicate that ER stress induces an early increase in mitochondrial metabolism that depends crucially upon organelle coupling and Ca2+ transfer, which, by enhancing cellular bioenergetics, establishes the metabolic basis for the adaptation to this response.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | BRAVO-SAGUA, ROBERTO FRANCISCO | Hombre |
Universidad de Chile - Chile
|
| 2 | VICENCIO-BUSTAMANTE, JOSE MIGUEL | Hombre |
Universidad de Chile - Chile
UCL - Reino Unido University College London - Reino Unido |
| 3 | PARRA-ORTIZ, VALENTINA | Mujer |
Universidad de Chile - Chile
|
| 4 | TRONCOSO-COTAL, RODRIGO HERNAN | Hombre |
Universidad de Chile - Chile
|
| 5 | MUNOZ-NECULMAN, JUAN PABLO | Hombre |
Univ Barcelona - España
Universitat de Barcelona - España |
| 6 | Bui, Michael | Hombre |
Univ Alberta - Canadá
University of Alberta - Canadá |
| 7 | QUIROGA-LAGOS, CLARA ROSA | Mujer |
Universidad de Chile - Chile
|
| 8 | RODRIGUEZ-VILLARROEL, ANDREA ELIZABETH | Hombre |
Universidad de Chile - Chile
|
| 9 | VERDEJO-PINOCHET, HUGO EDUARDO | Hombre |
Universidad de Chile - Chile
Pontificia Universidad Católica de Chile - Chile |
| 10 | FERREIRA-PARKER, JORGE FEDERICO | Hombre |
Universidad de Chile - Chile
|
| 11 | Iglewski, Myriam | Mujer |
Univ Texas SW Med Ctr Dallas - Estados Unidos
UT Southwestern Medical School - Estados Unidos |
| 12 | CHIONG-LAY, MARIO MARTIN | Hombre |
Universidad de Chile - Chile
|
| 13 | Simmen, Thomas | Hombre |
Univ Alberta - Canadá
University of Alberta - Canadá |
| 14 | Zorzano, Antonio | Hombre |
Univ Barcelona - España
Universitat de Barcelona - España |
| 15 | Hill, Joseph A. | Hombre |
Univ Texas SW Med Ctr Dallas - Estados Unidos
UT Southwestern Medical School - Estados Unidos |
| 16 | Rothermel, Beverly A. | Mujer |
Univ Texas SW Med Ctr Dallas - Estados Unidos
UT Southwestern Medical School - Estados Unidos |
| 17 | Szabadkai, Gyorgy | - |
UCL - Reino Unido
University College London - Reino Unido |
| 18 | LAVANDERO-GONZALEZ, SERGIO | Hombre |
Universidad de Chile - Chile
Univ Texas SW Med Ctr Dallas - Estados Unidos UT Southwestern Medical School - Estados Unidos |
| Fuente |
|---|
| FONDAP |
| CONICYT, Chile |
| National Institutes of Health |
| Generalitat de Catalunya |
| National Heart, Lung, and Blood Institute |
| American Heart Association |
| Ministerio de Educación y Ciencia (MEC) |
| Seventh Framework Programme |
| NSERC |
| Parkinson's UK |
| American Heart Association-Jon Holden DeHaan Foundation |
| CIBERDEM (Instituto de Salud Carlos III) |
| CCSRI |
| AI-HS |
| Agradecimiento |
|---|
| This work was supported by CONICYT, Chile (FONDECYT grant 1080436 and FONDAP grant 15010006 to S. L.), Parkinson's UK (grant G-0905 to G. S.), the National Institutes of Health (to J.A.H. and B. A. R.), the American Heart Association (to M. I., J.A.H. and B. A. R.), the American Heart Association-Jon Holden DeHaan Foundation (to J.A.H. and B. A. R.), NSERC grant 386757-2010 (to T. S.), CCSRI grant 2010-700306 (to T. S.), AI-HS scholarship 200500396 (to T. S.) and the Ministerio de Educacion y Ciencia (MEC, SAF2008-03803 to A.Z.), grant 2009SGR915 from the Generalitat de Catalunya (to A.Z.) and CIBERDEM (Instituto de Salud Carlos III to A.Z.). We thank CONICYT, Chile for the doctoral fellowships to R. B., V. P., C. Q. and A. E. R., for the postdoctoral support (FONDAP) to J.M.V. and the postdoctoral fellowship 3110114 from to R. T.; we thank Becas Chile for the postdoctoral funding to J.M.V. We thank David Chan (Pasadena, CA) for Mfn2 wild-type and knockout cells. We also thank Carla Ortiz, Cristian Ibarra and Aleck W. Jones for helpful discussions regarding this manuscript. We thank Fidel Albornoz and Ruth Marquez for excellent technical assistance. S. L. is on a sabbatical leave at the University of Texas Southwestern Medical Center, Dallas, Texas, USA. The authors declare no conflicts of interest. Deposited in PMC for release after 12 months. |